FSIPP has been a leader in promoting fair legislation, access to care and protecting reimbursement. We continue to educate payors, state officials and organizations regarding our area of expertise. We must take ownership of our speciality, promote well developed research and continue to expand our mission in the public and political arena.
To promote the development and practice of safe, high quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to interventional pain medicine (or management) doctors and these treatments in the State of Florida.
The Final Rule of the CMS Merit-Based Incentive Payment System, MIPS, and Alternative Payment Models, APMs, was published on 10/14/16, and is ~ 2,300 pages. Identified as the Quality Payment Program, QPP, it is extensive in scope to reward or penalize providers for performing certain measures in four performance categories. The four categories are: (1) Quality(2) Cost(3) Improvement Activities, and (4) Advancing Care Information. The four categories result in a final score of between 0 to 100 points. Depending on the provider's final score, a penalty/reward is assessed, or the provider remains neutral. For 2017 the penalty is 4%, but the bonus could be 3 to 4 times that amount. MIPS replaces PQRS, MU, and the VM (value modifier) programs, but rolls these same programs into the 3 performance categories above and the new category, Improvement Activities. This Webinar should educate physicians and their managers on how to understand and potentially achieve high scores in the new Quality Payment Program and avoid costly penalties in their Medicare Part B claims.
WEBINAR FEE: $185
WEBINAR DATE: January 19, 2017
TIME: 3:00pm-4:30pm CST
LENGTH: 90 Minutes
SPEAKER: Deborah H. Tracy, MD, MBA
Click here for full details and to register.
December 2, 2016
Just 6 days to show you stand against the sweeping recommendation to eliminate coverage for spinal interventional techniques in Oregon.
The Oregon Health Evidence Review Commission, without fanfare and without even looking at the literature appropriately, is eliminating coverage for what appears to be ALL spinal interventional techniques, now or in the next few months. They have issued draft coverage guidance strongly recommending against coverage for epidural, facet joint, medial branch, and sacroiliac joint injections for low back pain, regardless of etiology.
August 29, 2016
Dear FSIPP Members,
The purpose of this information is to help your hospital administrators and leading clinicians submit comments to CMS about its proposed reimbursement reduction for vertebral augmentation in CY17. Based upon Medicare's own data, Vertebral Augmentation should be reassigned to a Level 5 procedure. The suggested comment below needs to be submitted to CMS before September 6, 2016 @ 5pm (est). It is very easy to submit an online comment via this link:
August 5, 2016
Congratulations to Dr. Orlando Florete, President of FSIPP, for being elected to the FMA's Specialty Society Section’s Governing Council as a At-Large Member.
Clinical Diagnosis and Management
Andrea M. Trescot, MD
Medical Director - Pain and Headache Center
Featured as a single volume, this is a comprehensive guide to possible nerve entrapment syndromes and their management. Click here for Free Preview and to order.
May 27, 2016
REGARDING: CMS News Update - The Pulse of CMS Spring 2016
Click Here to download the entire edition.
Harold Cordner, MD
The use of opioids to treat acute and chronic nonmalignant and malignant pain has steadily increased since the late 1990s. With this increase in opioid use, prescription opioid abuse increased to epidemic proportions. In 2012, an estimated 2.1 million Americans suffered through substance-abuse problems related to prescription opioid pain relievers. Florida was the epicenter of prescription-drug abuse, overdose deaths and "pill mills."
Since 2010, the state of Florida has drastically reduced the accidental deaths due to prescription opioid abuse through legislation, the enactment of the Prescription Drug Monitoring Program, the crackdown on pill mills and other means.
FSIPP President Harold L Dalton, DO in attendance.
DEERFIELD BEACH, Fla. —Fear of the DEA has been a recurring theme in the WESH 2 News ongoing investigation of Florida's prescription drug problem. Patients with real health issues are being denied the medication.
The DEA said it would answer those accusations at Florida's Board of Pharmacy hearing Monday.
"We don't want people to fear us, ...
Articles on Genetics Testing in Pain Management
Reserved for those who donate to the FSIPP PAC or to FSIPP.
Our parent organization is ASIPP, the American Society of Interventional Pain Physicians. Visit ASIPPs website, for a bountiful resource for pain practitioners, and to review a list of ASIPPs accomplishments which have greatly benefited both pain patients and pain physicians.
Dr. Maulik Bhalani is looking to purchase a Super c C-arm GE OEC, 3 Motion C-arm table. If anyone is looking to sell, please contact him at:
Maulik Bhalani, MD
Florida Pain Medicine
2553 Windguard Circle
Wesley Chapel, FL 33544